HCW Biologics Strengthens HCW9302 Patent for Alopecia Areata
MIRAMAR, Fla., Sept. 2, 2026 HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for autoimmune...
Phase 1
Advertisement
Treeline Partners With Roche to Evaluate TLN-121 in Lymphoma
WATERTOWN, Mass., September 2, 2026 Treeline Biosciences, Inc. announced a clinical trial collaboration and supply agreement with Roche to...
Adicet Bio Advances Prula-Cel Toward SLE Data Readout
REDWOOD CITY, Calif., September 1, 2026 Adicet Bio announced completion of the last patient visit for the planned Phase...
Rectify Advances RTY-406 as Potential Disease-Modifying Therapy for PSC
Boston, Mass. – August 27, 2026 Rectify Pharmaceuticals presented the discovery and characterization of RTY-406, an oral, once-daily investigational...
Apollo Therapeutics Reports Positive APL-10456 Phase 1 Data
BOSTON, U.S. & CAMBRIDGE, U.K. — August 25, 2026 Apollo Therapeutics announced positive immunogenicity and cross-species activity data from...
Advertisements
BioCryst Wins Japan Approval for Pediatric ORLADEYO
TOKYO, Japan — August 25, 2026 BioCryst Pharmaceuticals announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
Basking Biosciences Reports Positive Phase 1 Data for BB-025
RESEARCH TRIANGLE, North Carolina — August 25, 2026 Basking Biosciences announced positive topline Phase 1 data for BB-025, an...
Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech
SEOUL, South Korea, August 24, 2026 Hanmi Pharm announced an exclusive global licensing agreement with Genentech, a member of...
Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs
August 24, 2026 | San Jose, California Anixa Biosciences announced that it will present updates on its breast cancer...
AbbVie Highlights Lung Cancer Pipeline Data at WCLC 2026
North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...
Advertisement
